Abstract:Antidiabetic agents simultaneously inhibiting hepatic glucose production and stimulating hepatic glucose consumption could apply a better control over hyperglycemia. A series of oleanolic acid derivatives with bulky substituents at C‐3 position were designed and synthesized in order to search for this kind of agents. All of the compounds were evaluated biologically in vitro using glycogen phosphorylase and HepG2 cells. The results indicated that several derivatives exhibited moderate‐to‐good inhibitory activities against glycogen phosphorylase. Compound 8g showed the best inhibition with an IC50 value of 5.4 μm. Moreover, most of the derivatives were found to increase the glucose consumption in HepG2 cells in a dose‐dependent manner. The possible binding mode of compound 8g with glycogen phosphorylase was also explored by docking study. 8g was found to have hydrogen bonding interactions with Arg193, Arg310, and Arg60 of the allosteric site.

Synthesis and Biological Evaluation of Ambradiolic Acid As an Inhibitor of Glycogen Phosphorylase

Synthesis Of 3-Deoxypentacyclic Triterpene Derivatives As Inhibitors Of Glycogen Phosphorylase

Practical Synthesis of Bredemolic Acid, a Natural Inhibitor of Glycogen Phosphorylase

Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase

Synthesis and Biological Evaluation of Ursolic Acid Derivatives As Novel Inhibitors of Glycogen Phosphorylase

Pentacyclic triterpenes. Part 2: Synthesis and biological evaluation of maslinic acid derivatives as glycogen phosphorylase inhibitors.

Terpenoids. III: Synthesis and biological evaluation of 23-hydroxybetulinic acid derivatives as novel inhibitors of glycogen phosphorylase.

Synthesis and Biological Activity of Heterocycle-Fused Derivatives of Pentacylic Triterpenes As Glycogen Phosphorylase Inhibitors

Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies.

Synthesis of oleanolic acid dimers as inhibitors of glycogen phosphorylase.

Synthesis and biological evaluation of novel pyrazolo[4,3-b]oleanane derivatives as inhibitors of glycogen phosphorylase.

Synthesis and biological evaluation of asiatic acid derivatives as inhibitors of glycogen phosphorylases.

Synthesis and Biological Evaluation of Arjunolic Acid, Bayogenin, Hederagonic Acid and 4-Epi-hederagonic Acid as Glycogen Phosphorylase Inhibitors

Synthesis and Evaluation of Novel Oleanolic Acid Derivatives As Potential Antidiabetic Agents

Pentacyclic Triterpenes. Part 5: Synthesis and SAR Study of Corosolic Acid Derivatives As Inhibitors of Glycogen Phosphorylases.

Design, Synthesis, and Evaluation of 3‐aryl‐4‐pyrrolyl‐maleimides As Glycogen Synthase Kinase‐3β Inhibitors

Synthesis of glucoconjugates of oleanolic acid as inhibitors of glycogen phosphorylase.

Pentacyclic triterpenes. Part 1: the first examples of naturally occurring pentacyclic triterpenes as a new class of inhibitors of glycogen phosphorylases

Synthesis and Biological Evaluation of Substituted Phenylpyrazole[4,5-B]oleanane Derivatives As Inhibitors of Glycogen Phosphorylase.

Synthesis and Evaluation of C-28 Oleanolic Acid Derivatives As Inhibitors of Glycogen Phosphorylase

Design, Synthesis and Evaluation of Pentacyclic Triterpenoids Similar to Glycyrrhetinic Acid Via Combination of Chemical and Microbial Modification As Glycogen Phosphorylases Inhibitor